The renin-angiotensin system in acute respiratory distress syndrome

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 2, 2006, Pages 225-229

  Imai, Yumiko ^a   Kuba, Keiji ^a   Penninger, Josef M ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR AGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN; VIRUS RECEPTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLELE; ANTIOXIDANT ACTIVITY; BLOOD VESSEL PERMEABILITY; CORRELATION ANALYSIS; DRUG TARGETING; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LUNG BLOOD VESSEL; LUNG EDEMA; LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33748497602     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.06.012     Document Type: Review

References (28)

1. Skeggs L.T., et al. The biochemistry of the renin-angiotensin system. Adv. Exp. Med. Biol. 130 (1980) 1-27
2. Corvol P., et al. Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol. 248 (1995) 283-305
3. Donoghue M., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87 (2000) E1-E9
4. Tipnis S.R., et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275 (2000) 33238-33243
5. Li W., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
6. Peiris J.S., et al. Severe acute respiratory syndrome. Nat. Med. 10 12 Suppl. (2004) S88-S97
7. Imai Y., et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 (2005) 112-116
8. Kuba K., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 (2005) 875-879
9. Grose C., and Chokephaibulkit K. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr. Infect. Dis. J. 23 (2004) 793-794
10. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342 (2000) 1334-1349
11. Cambien F., et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 43 (1988) 774-780
12. Rigat B., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86 (1990) 1343-1346
13. Marshall R.P., et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 166 (2002) 646-650
14. Jerng J.S., et al. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit. Care Med. 34 (2006) 1001-1006
15. Idell S., et al. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 91 (1987) 52-56
16. Orfanos S.E., et al. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 102 (2000) 2011-2018
17. Mortensen E.M., et al. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia. BMC Pulm. Med. 5 (2005) 12
18. Crackower M.A., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
19. Yamamoto K., et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47 (2006) 718-726
20. Kiely D.G., et al. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc. Res. 33 (1997) 201-208
21. Xu Z.H., et al. Pulmonary edema induced by angiotensin I in rats. Jpn. J. Pharmacol. 76 (1998) 51-56
22. Yamamoto T., et al. Angiotensin II-induced pulmonary edema in a rabbit model. Jpn. J. Pharmacol. 73 (1997) 33-40
23. Victorino G.P., et al. Effect of angiotensin II on microvascular permeability. J. Surg. Res. 104 (2002) 77-81
24. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug Discov. 3 (2004) 845-852
25. Schanstra J.P., et al. Bradykinin B(1) receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation. J. Am. Soc. Nephrol. 11 (2000) 1208-1215
26. Vickers C., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277 (2002) 14838-14843
27. Raiden S., et al. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits neutrophil recruitment in the lung triggered by fMLP. J. Leukoc. Biol. 68 (2000) 700-706
28. Lukkarinen H., et al. Angiotensin II receptor blockade inhibits pneumocyte apoptosis in experimental meconium aspiration. Pediatr. Res. 55 (2004) 326-333